Beta Drugs Limited IPO

Add to Calendar 2017-09-29 12:00 AM 2017-10-04 12:00 AM Asia/Kolkata Beta Drugs Limited IPO Beta Drugs Limited India

Beta Drugs Limited is a pharmaceutical company manufacturing ,developing and marketing of drug products. Company’s manufacturing unit is an ISO 9001:2008 certified facility located at Kharuni –Lodhimajra Road, Dist - Solan Himachal Pradesh. Company started production of oncology products by manufacturing portfolio of over 35 products which is used for the treatment of various cancer disease. As on March 31, 2017, firm had a portfolio of over 50 products catering to various oncology diseases.

Date of establishment: Beta Drugs Limited was incorporated in 1979

Product & Service Offering: Their products include anti-cancer tablets, capsules, injections and lyophilized injections. Company has portfolio of over 50 products which is used for the treatment of various cancer diseases.


Promoters of Beta Drugs ltd.: Mr Vijay Kumar Batra is the promoters of Beta Drugs Limited.


Customer segment: It sell drugs to domestic & international customers


Objects of the Issue:The objects of the Offer is to:-
-     To Finance purchase of new plant and machinery and upgradation of our existing plant and machinery
-     To Finance Civil Construction work at existing manufacturing unit.
-     To obtain registration of European Union GMP & Pharmaceutical Inspection Co-operation Scheme certificate
-     To Finance Working capital requirements
-     To Finance General corporate expense

Company Financials:

Beta Drugs' financial performance (in INR lakh)







Total Assets







Total revenue







Total expenses







Profit after tax







Issue Detail

  • Issue Open: Sep 29, 2017
  • Issue Close: Oct 04, 2017
  • Issue Type: Fixed Price Issue IPO
  • Face Value: Rs 10 Per Equity Share
  • Price Band: Rs 85 Per Equity Share
  • Bid Lot:1600 Shares
  • Minimum Order Quantity:1600 Shares
  • Listing At: NSE SME
  • Issue Size: • Rs 19.52 Cr

Current Bidding Status

Number of Times Subscribed (BSE + NSE)
As on Date & Time QIB NII RII Employee Others Total
Day 0 - Sep 29, 2017IST 0 129,600 52,800 - - 182,400
Day 1 - Oct 03, 2017IST 0 854,400 668,800 - - 1,523,200
Day 2 - Oct 04, 2017IST 316,800 32,235,200 8,664,000 - - 41,216,000

Listing Day Trading Information

Issue Price - Rs 85.00
Open - Rs 102.00
Low - Rs 92.00
High - Rs 102.00
Last Trade - Rs 101.95
Volume - 2,211,200

Beta Drugs Limited Red Herring Prospectus

Beta Drugs Limited User Rating


Beta Drugs Limited Life IPO Reviews

Beta Drugs Limited IPO News & Updates

Frequently Asked Questions

Yes, you can always trade an IPO through a discount broker. Buying & selling an IPO becomes very easy once the trading and the demat account are set up appropriately.
Following are the benefits in buying and selling an IPOs through a discount broker. Reduced Brokerage Fee: Discount brokers charge a flat brokerage which is missing in case of full service brokers. Full service brokers usually charge %age brokerage and this incurs a lot of cost to an investors. So if any full service broker charge a brokerage of let say 0.03% then on a purchase of shares of worth of Rs 200,000 you end up paying Rs 600+ Taxes. In our case we charge a flat brokerage of Rs 20 + Taxes. Discount brokers therefore saves a lot of money of investors. Better Trading Platform: Usually discounts brokers don’t provide a good trading platform and experience but there are few discounts brokers like Samco, who are now focussing on delivering a world class trading platform and top notch user experience. Therefore narrowing down the gap between discount brokers and full service brokers.
Technically Speaking, SEBI has made mandatory to buy an IPO through ASBA channel but there is no regulation on how any investor can sell an IPO allotted shares. Therefore, smart investors can always sell IPO allotted shares through a discount broker


Start IPO Trading through SAMCO

Don't have a Trading Account !!!
Open an account with Samco and Do IPO Trading for Just Rs 20. For more details, share your contact details with us